2002
DOI: 10.1016/s0090-4295(01)01565-5
|View full text |Cite
|
Sign up to set email alerts
|

Long-term recurrence of primary amyloidosis of the bladder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 6 publications
0
5
0
Order By: Relevance
“…Regardless of lesional size, isolated amyloidosis of the genitourinary tract has been reported to have a high recurrence rate (>50%); however, no disease-associated mortality has been reported [18]. Following an initial systemic work-up for amyloidosis, long-term follow-up is recommended as recurrences have been reported several years after initial diagnosis [17,26]. …”
Section: Resultsmentioning
confidence: 99%
“…Regardless of lesional size, isolated amyloidosis of the genitourinary tract has been reported to have a high recurrence rate (>50%); however, no disease-associated mortality has been reported [18]. Following an initial systemic work-up for amyloidosis, long-term follow-up is recommended as recurrences have been reported several years after initial diagnosis [17,26]. …”
Section: Resultsmentioning
confidence: 99%
“…Computed tomography shows single or multiple bulging lesions on the bladder wall, which can be easily confused with bladder malignancies. 8 …”
Section: Discussionmentioning
confidence: 99%
“… 6 Although many treatment methods are available the recurrence rate of this disease is as high as 54%, 7 Delayed recurrence may occur 14 years after the first diagnosis. 8 Dimethyl sulfoxide (DMSO) bladder perfusion can be used to treat or prevent recurrence, and one treatment course lasts for 6 to 12 months. 9 There are also reports of satisfactory outcomes by administration of cephalexin together with bladder infusion of DMSO.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this regard, we have observed induction of established tubular markers within primary cultures of KiSAS cells in response to modulation with known morphogenic agents such as retinoic acid (our unpublished observations). Renal adipose may represent a potentially ideal alternate cell source for treatment of chronic anemia secondary to CKD, since renal adipose can be isolated in much larger quantities than renal primary cells and, as is the case for adipose associated with tubular organs such as bladder, may be unaffected by the occurrence of metastasis in renal cancer patients [46,47]. …”
Section: Discussionmentioning
confidence: 99%